BAY-293 : Pan-KRAS inhibitors suppress proliferation through feedback regulation in pancreatic ductal adenocarcinoma

Rogaratinib: A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours

KRpep-2d : Motif-guided identification of KRAS-interacting proteins